This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Diagnostic Laboratory Services, Inc. (DLS), a for-profit subsidiary of The Queens Health Systems, a non-profit healthcare organization. The contract is for $2,315,616.16 to provide tuberculosis laboratory testing services for the U.S.-Affiliated Pacific Islands.
The contract is a cost-plus-fixed-fee type and has a period of performance through September 24, 2020. DLS, as the prime contractor, will deliver comprehensive laboratory testing services including specimen transport, smear microscopy, culture, identification, and specialized diagnostic procedures across multiple locations in Hawaii, Guam, Saipan, and American Samoa. This contract does not have a set-aside designation.
DLS has a history of providing laboratory testing services to federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and CDC, through both stand-alone contracts and an indefinite delivery contract with the VA worth up to $4,000,000. The Queens Health Systems, as the parent organization, may have additional federal contract and grant awards, but specific details are not provided.